Prosecution Insights
Last updated: October 25, 2026

AMOREPACIFIC Corporation

Technology area: Biotechnology & Pharmaceuticals

25 pending office actions • 13 art units • 24 examiners • 0 of 25 (0%) have an AI response strategy ready • 25 patents granted in the last 365 days

Analysis

AMOREPACIFIC Corporation has 25 pending office actions in Biotechnology & Pharmaceuticals. The matters involve 24 distinct examiners and 13 distinct art units, reflecting broad distribution across the examination organization.

BORI, IBRAHIM D is the busiest examiner, with 2 pending matters. The limited concentration relative to the overall docket means that prosecution management should emphasize application-specific tracking, art-unit coordination, and consistent technical positions across separate examiner interactions.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Portfolio Summary

25
Total Pending OAs
17
Non-Final OAs
8
Final Rejections
0
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 5 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

1
Overdue
0
Due this week
2
Due this month
2
Due in next 60 days
0
Due later

Deadline Fire Line

Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 5 of the docket's apps have a known mailing date.

-30dToday30d60d90d120d
Overdue (1)Due ≤ 30 days (2)Due ≤ 60 days (2)

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

9
Hard (36%)
15
Medium (60%)
1
Easy (4%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
§103 only8 (32%)
§112 only1 (4%)
Double-patenting + other7 (28%)
Multi-statute (no §101)9 (36%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

23
Life Sciences
92% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
0
Semiconductors
0% of docket
2
Mechanical / Eng
8% of docket
0
Business / Other
0% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

250 h
Manual time on pending OAs
50 h
Time saved (low, 20%)
88 h
Time saved (mid, 35%)
2.2 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
BORI, IBRAHIM D 2 43.9% +39.0%
KRINOS, EMILY LYNN 1 — —
PRAGANI, RAJAN 1 52.4% +71.4%
VIGIL, TORIANA NICHOLE 1 52.9% +26.8%
TOWNSLEY, SARA ELIZABETH 1 25.6% +48.2%
MCINTOSH III, TRAVISS C 1 73.3% +14.1%
CHO, DAVID H 1 31.9% +67.0%
BRAM, STANLEY 1 0.0% +0.0%
HOFFMAN, SUSAN COE 1 54.2% +25.7%
WOODHOUSE, SARAH ANN 1 29.3% +65.0%

Hard Cases (12)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 8 ordered by deadline are shown.

App #TitleExaminerDue in
17512381 GINSENG POWDER, COSMETIC COMPOSITION COMPRISING SAME AND PREPARATION METHOD THEREOF BERRIOS, JENNIFER A 20d
18515599 COMPOSITION FOR ANTI-OBESITY COMPRISING GREEN TEA PEPTIDE COMPOSITION MOREAU, NASHARA LOUISE 33d
19081165 COMPOSITION FOR EXTERNAL USE ON SKIN FOR REDUCING SKIN WRINKLES CONTAINING POLYVINYL ALCOHOL KRINOS, EMILY LYNN —
18960938 COMPOSITION FOR CELLULAR DNA DAMAGE REPAIR COMPRISING KAEMPFEROL SACCHARIDES COMPOUNDS VIGIL, TORIANA NICHOLE —
18917401 COMPOSITION FOR PREVENTING OR IMPROVING SKIN-AGING CONTAINING A THYMOL ESTER-BASED COMPOUND TOWNSLEY, SARA ELIZABETH —
18829496 COMPOSITION FOR ENHANCING SKIN VITALITY CONTAINING A THYMOL ESTER-BASED COMPOUND BRAM, STANLEY —
18757797 SENOTHERAPY COMPOSITION CONTAINING CAMELLIA SINENSIS EXTRACT HOFFMAN, SUSAN COE —
18756290 APPLICATOR FOR ATTACHING PATCH TO THE SKIN WOODHOUSE, SARAH ANN —

Interview Candidates (9)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.

App #TitleExaminerDue in
19043831 COSMETIC COMPOSITIONS FOR LIPS COMPRISING COLORANTS PRAGANI, RAJAN —
18990489 COMPOSITION FOR PROTECTING SKIN CONTAINING A THYMOL ESTER-BASED COMPOUND BORI, IBRAHIM D —
18968486 COMPOSITION FOR PROMOTING HAIR SPROUTING OR HAIR GROWTH CONTAINING A THYMOL ESTER-BASED COMPOUND BORI, IBRAHIM D —
18960938 COMPOSITION FOR CELLULAR DNA DAMAGE REPAIR COMPRISING KAEMPFEROL SACCHARIDES COMPOUNDS VIGIL, TORIANA NICHOLE —
18917401 COMPOSITION FOR PREVENTING OR IMPROVING SKIN-AGING CONTAINING A THYMOL ESTER-BASED COMPOUND TOWNSLEY, SARA ELIZABETH —
18883178 COMPOSITION FOR CONTROLLING BLOOD SUGAR COMPRISING GALLOCATECHIN GALLATE AND ISOQUERCITRIN MCINTOSH III, TRAVISS C —
18883218 COMPOSITION FOR IMPROVING FATIGUE, EXERCISE PERFORMANCE, OR ENDURANCE COMPRISING GALLOCATECHIN GALLATE AND ISOQUERCITRIN CHO, DAVID H —
18757797 SENOTHERAPY COMPOSITION CONTAINING CAMELLIA SINENSIS EXTRACT HOFFMAN, SUSAN COE —

Top Art Units

Art UnitApps
1693 5
1614 4
1629 3
1655 3
3772 2
1612 1
1691 1
1654 1
1797 1
1617 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
19081165 COMPOSITION FOR EXTERNAL USE ON SKIN FOR REDUCING SKIN WRINKLES CONTAINING POLYVINYL ALCOHOL KRINOS, EMILY LYNN 1614 §102§103§112 Non-Final OA — Pending Mar 17, 2025
19043831 COSMETIC COMPOSITIONS FOR LIPS COMPRISING COLORANTS PRAGANI, RAJAN 1614 §103 Non-Final OA — Pending Feb 03, 2025
18990489 COMPOSITION FOR PROTECTING SKIN CONTAINING A THYMOL ESTER-BASED COMPOUND BORI, IBRAHIM D 1629 §102§103DP Non-Final OA — Pending Dec 20, 2024
18968486 COMPOSITION FOR PROMOTING HAIR SPROUTING OR HAIR GROWTH CONTAINING A THYMOL ESTER-BASED COMPOUND BORI, IBRAHIM D 1629 §103DP Non-Final OA — Pending Dec 04, 2024
18960938 COMPOSITION FOR CELLULAR DNA DAMAGE REPAIR COMPRISING KAEMPFEROL SACCHARIDES COMPOUNDS VIGIL, TORIANA NICHOLE 1612 §102§103§112 Non-Final OA — Pending Nov 26, 2024
18917401 COMPOSITION FOR PREVENTING OR IMPROVING SKIN-AGING CONTAINING A THYMOL ESTER-BASED COMPOUND TOWNSLEY, SARA ELIZABETH 1629 §102§103§112DP Non-Final OA — Pending Oct 16, 2024
18883178 COMPOSITION FOR CONTROLLING BLOOD SUGAR COMPRISING GALLOCATECHIN GALLATE AND ISOQUERCITRIN MCINTOSH III, TRAVISS C 1693 §103DP Non-Final OA — Pending Sep 12, 2024
18883218 COMPOSITION FOR IMPROVING FATIGUE, EXERCISE PERFORMANCE, OR ENDURANCE COMPRISING GALLOCATECHIN GALLATE AND ISOQUERCITRIN CHO, DAVID H 1693 §103DP Non-Final OA — Pending Sep 12, 2024
18829496 COMPOSITION FOR ENHANCING SKIN VITALITY CONTAINING A THYMOL ESTER-BASED COMPOUND BRAM, STANLEY 1691 §103§112DP Non-Final OA — Pending Sep 10, 2024
18757797 SENOTHERAPY COMPOSITION CONTAINING CAMELLIA SINENSIS EXTRACT HOFFMAN, SUSAN COE 1655 §102§112 Non-Final OA — Pending Jun 28, 2024
18756290 APPLICATOR FOR ATTACHING PATCH TO THE SKIN WOODHOUSE, SARAH ANN 3772 §103 Final Rejection — Pending Jun 27, 2024
18663736 COMPOSITION FOR REDUCING BODY FAT CONTAINING GALLOCATECHIN GALLATE AND ISOQUERCITRIN MILLER, DALE R 1693 §102§103DP Non-Final OA — Pending May 14, 2024
18618666 COMPOSITION FOR LOWERING BLOOD SUGAR CONTAINING GREEN TEA PEPTIDE COMPOSITION GARYU, LIANKO G 1654 §102§103§112Other Non-Final OA — Pending Mar 27, 2024
18515599 COMPOSITION FOR ANTI-OBESITY COMPRISING GREEN TEA PEPTIDE COMPOSITION MOREAU, NASHARA LOUISE 1655 §102§103 Non-Final OA 33d Pending Nov 21, 2023
18495271 MICROFLUIDIC CHIP AND COSMETIC MANUFACTURING APPARATUS INCLUDING SAME ALABI, OYELEYE A 1797 §102§103§112 Non-Final OA — Pending Oct 26, 2023
18213540 REFILLABLE COSMETIC CONTAINER RUIZ MARTIN, LUIS MIGUEL 3772 §102§103§112 Non-Final OA — Pending Jun 23, 2023
18325484 COMPOSITION FOR REDUCING THE ABSORPTION OF MICROPLASTICS JUSTICE, GINA CHIEUN YU 1617 §112 Non-Final OA — Pending May 30, 2023
18200005 APPARATUS FOR MANUFACTURING COSMETICS SORKIN, DAVID L 1774 §102§103 Final Rejection — Pending May 22, 2023
18316545 COMPOSITION FOR COLOR CHANGING BEVERAGES CONTAINING ANTHOCYANINS MERRIAM, ANDREW E 1791 §103 Final Rejection 23d Pending May 12, 2023
18305840 WATER DISPERSABLE FILM-FORMING COMPOSITION BRANDSEN, BENJAMIN MICHAEL 1693 §103 Final Rejection — Pending Apr 24, 2023
18096335 SKIN EXTERNAL COMPOSITION AND METHOD FOR PREPARING THE SAME CAIN, JENNIFER LYNN 1655 §103 Final Rejection — Pending Jan 12, 2023
18065228 REELIN/VEGF-C PRODUCTION/ACTIVATION PROMOTER AND SKIN EXTERNAL COMPOSITION USING THE SAME HIBSHMAN, SARAH GRACE 1693 §103 Final Rejection 3d overdue Pending Dec 13, 2022
17512381 GINSENG POWDER, COSMETIC COMPOSITION COMPRISING SAME AND PREPARATION METHOD THEREOF BERRIOS, JENNIFER A 1613 §103§112 Final Rejection 20d Pending Oct 27, 2021
17353118 SURFACE-TREATED INORGANIC PARTICLES, MANUFACTURING METHOD OF THE SAME, DISPERSION SOLUTION OF THE SAME, AND COSMETIC COMPOSITION INCLUDING THE SAME KETCHAM, KAREN A 1614 §103 Final Rejection — Pending Jun 21, 2021
16934797 COMPOSITION OF FREEZE-DRIED FORMULATION, COSMETIC KIT FOR EXTERNAL USE ON SKIN INCLUDING THE SAME, AND METHOD FOR SKIN MOISTURIZING INCLUDING APPLYING THE SAME ONTO THE SKIN YU, HONG 1614 §103 Non-Final OA 54d Pending Jul 21, 2020

Managing AMOREPACIFIC Corporation's Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Frequently Asked Questions

How many pending USPTO office actions does AMOREPACIFIC Corporation have?

AMOREPACIFIC Corporation has 25 pending office actions as of October 2026, spread across 13 art units and 24 examiners.

Which USPTO examiner handles the most AMOREPACIFIC Corporation applications?

Ibrahim D Bori has the most, with 2 of AMOREPACIFIC Corporation's pending office actions.

What technology area are AMOREPACIFIC Corporation's patent applications in?

Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month